drugset / Trial / NCT03449069
Pediatric MSC-AFP Sub-study for Crohn's Fistula
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety of using an autologous mesenchymal stromal cell (MSC) coated fistula plug in people with fistulizing Crohn's disease. Autologous means these cells to coat the plug come from the patient.
Timeline
- Start
- 2018-07-23
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MSC-AFP | Cell therapy | 2e+07 cells | — |